Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -7.97% is 69% above its 5-year average of -26.13%, near the high end of its 5-year range (-75.05%–-4.41%).
0.03% above its 12-month average of -7.97%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -7.46%.
OPERATING MARGIN
-7.97%
OPERATING MARGIN AVG TTM
-7.97%
OPERATING MARGIN AVG 3Y
-11.79%
OPERATING MARGIN AVG 5Y
-26.13%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.03%
CURRENT VS 3Y AVG
+32.38%
CURRENT VS 5Y AVG
+69.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Strata Critical Medical, Inc.
Market Cap
$411.00M
Operating Margin
-7.97%
TTM Avg
-7.97%
3Y Avg
-11.79%
5Y Avg
-26.13%
Market Cap
$411.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$406.58M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$405.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.78%
Market Cap
$416.27M
Operating Margin
-193.83%
TTM Avg
-263.44%
3Y Avg
-320.82%
5Y Avg
-550.06%
Market Cap
$404.24M
Operating Margin
-12.22%
TTM Avg
-9.37%
3Y Avg
-14.04%
5Y Avg
-19.79%
Market Cap
$418.95M
Operating Margin
-245.15%
TTM Avg
-511.19%
3Y Avg
-596.30%
5Y Avg
-548.32%
Market Cap
$402.17M
Operating Margin
0.00%
TTM Avg
-4465.14%
3Y Avg
-2232.57%
5Y Avg
-1488.38%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Strata Critical Medical, Inc. (SRTA) | $411.00M | -7.97% | -7.97% | -11.79% | -26.13% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | 0.00% | 0.00% | 0.00% | 2.78% |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -193.83% | -263.44% | -320.82% | -550.06% |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | -12.22% | -9.37% | -14.04% | -19.79% |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | -245.15% | -511.19% | -596.30% | -548.32% |
| Neurogene Inc. (NGNE)vs › | $402.17M | 0.00% | -4465.14% | -2232.57% | -1488.38% |
| Prothena Corporation plc (PRTA)vs › | $419.87M | -1905.82% | -1010.09% | -618.33% | -2608.93% |
Gross Margin
20.6%
Operating Margin
-8.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -7.46% |
| 2026-03-31 | -4.41% |
| 2025-12-31 | -9.59% |
| 2025-09-30 | -11.40% |
| 2025-06-30 | -7.00% |
| 2025-03-31 | -13.96% |
| 2024-12-31 | -15.40% |
| 2024-09-30 | -4.72% |
| 2024-06-30 | -17.88% |
| 2024-03-31 | -19.16% |
| 2023-12-31 | -75.05% |
| 2023-09-30 | -10.43% |
| 2023-06-30 | -20.02% |
| 2023-03-31 | -28.33% |
| 2022-12-31 | -51.60% |
| 2022-09-30 | -22.81% |
| 2022-06-30 | -27.31% |
| 2022-03-31 | -51.41% |
| 2021-12-31 | -47.89% |
| 2021-09-30 | -42.80% |
| 2021-06-30 | -60.00% |
| 2021-03-31 | -45.56% |
| 2020-12-31 | -29.65% |
| 2020-09-30 | -8.79% |
| 2020-06-30 | -42.93% |
| 2020-03-31 | -51.87% |
| 2019-12-31 | -91.98% |
| 2019-09-30 | 0.00% |
